top of page
Cecilia joined the lab in 2022 as a PhD student. She obtained a MSc in Biotechnology at the French engineering school ENSTBB, in partnership with Sanofi. After graduating she joined the Kennedy Institute of Rheumatology from the University of Oxford to extensively study a binding between receptors and a possible drug for Rheumatoid Arthritis. Her PhD will be focused on the generation of a functional micro-environment for colon organoids to potentially study a treatment for sepsis.
bottom of page